| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,949 | 9,927 | 7,483 | 9,712 | | Cost of Revenue | 10,344 | 7,541 | 6,440 | 9,243 | | | Gross Profit | 2,605 | 2,386 | 1,043 | 469 | | | Operating Expenses | | Research Development | 416 | 413 | 521 | 421 | | Selling General and Administrative | 1,540 | 1,841 | 1,769 | 2,215 | | Non Recurring |
-
|
-
|
-
| 1,703 | | Others | 363 | 370 | 371 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 286 | (238) | (1,618) | (3,870) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 8 | 9 | 42 | | Earnings Before Interest And Taxes | 293 | (230) | (1,609) | (3,828) | | Interest Expense |
-
|
-
|
-
| 14 | | Income Before Tax | 293 | (230) | (1,609) | (3,842) | | Income Tax Expense | 10 | 10 | 8 | 26 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 283 | (240) | (1,617) | (3,868) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 283 | (240) | (1,617) | (3,868) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $283 | ($240) | ($1,617) | ($3,868) |
|
0.51% Nasdaq 
Income Statement
